4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001546927-15-000263
10% owner bought 4,000,423 shares at an average $1.00 ($4,000,436)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Camber Capital Management LLC 10% owner | 2015-10-19 | Purchase | +4,000,000 | $1.00 | $4,000,000 | 13,274,577 | I |
| Camber Capital Management LLC 10% owner | 2015-10-19 | Purchase | +423 | $1.03 | $436 | 13,275,000 | I |
| Open-market purchases · 4,000,423 sh · avg $1.00 · $4,000,436 | |||||||
Loading xslF345X03/camberprotalixform4filed.xml…